StockData
Annovis Bio, Inc. logo

Annovis Bio, Inc. (ANVS) stock

ANVSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.74−0.01 (-0.91%)

Close on Nov 17, 2026Market cap $31.66MP/E –Yield –

Annovis Bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Annovis Bio's market cap was $36.36M on Nov 11, 2026, against $102.96M a year earlier. Over the last 5 years it ranged from $21.07M to $168.53M, with a median of $85.53M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$36.36M-48.0%
2025Dec 31, 2025$69.85M+4.5%
2024Dec 31, 2024$66.82M-60.4%
2023Dec 29, 2023$168.53M+53.7%
2022Dec 30, 2022$109.64M-23.0%
2021Dec 31, 2021$142.41M+174.9%
2020Dec 31, 2020$51.81M–

More Annovis Bio figures

See a number that looks wrong?